The Carolina cognition study II: A sub-study of the multicentre, international, randomised, parallel group, double blind study to evaluate caardiovascular safety of linagliptin versus glimpiride in patients with type 2 diabetes mellitus at high cardiovascular risk (the CAROLINA trial)

Trial Profile

The Carolina cognition study II: A sub-study of the multicentre, international, randomised, parallel group, double blind study to evaluate caardiovascular safety of linagliptin versus glimpiride in patients with type 2 diabetes mellitus at high cardiovascular risk (the CAROLINA trial)

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Linagliptin (Primary) ; Glimepiride
  • Indications Type 2 diabetes mellitus; Vascular dementia
  • Focus Therapeutic Use
  • Acronyms Carolina Cognition Sub-study 2
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 12 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top